A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor

Journal of Medicinal Chemistry

Volumn 39, Issue 17, 1996, Pages 3324-3330

  Beyermann, Michael ^a   Fechner, Klaus ^a   Furkert, Jens ^a   Krause, Eberhard ^a   Bienert, Michael ^a  

^a LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; RECOMBINANT CORTICOTROPIN RELEASING FACTOR; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CORTICOTROPIN RELEASE; DRUG POTENCY; HORMONE RECEPTOR INTERACTION; LIPOPHILICITY; MALE; NONHUMAN; PEPTIDE ANALYSIS; RAT; SEQUENCE ANALYSIS; SHEEP; STRUCTURE ACTIVITY RELATION;

ADRENOCORTICOTROPIC HORMONE; AMINO ACID SEQUENCE; ANIMALS; BRAIN; CATTLE; CELL MEMBRANE; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORTICOTROPIN-RELEASING HORMONE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PITUITARY GLAND, ANTERIOR; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SEQUENCE HOMOLOGY, AMINO ACID; SHEEP; STRUCTURE-ACTIVITY RELATIONSHIP; SWINE;

EID: 0029786101     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960116z     Document Type: Article

References (47)

1. Rivier, J.; Rivier, C.; Vale, W. Synthetic competitive antagonists of corticotropin-releasing factor: Effect on ACTH secretion in the rat. Science 1984, 224, 889-891.
2. Kornreich, W. D.; Galyean, R.; Hernandez, J.-F.; Craig, A. G.; Donaldson, C. J.; Yamamoto, G.; Rivier, C.; Vale, W.; Rivier, J. Alanine series of ovine corticotropin-releasing factor (oCRF): A structure-activity relationship study. J. Med. Chem. 1992, 35, 1870-1876.
3. Vale, W.; Spiess, J.; Rivier, C.; Rivier, J. Characterization of a 41 residue ovine hypothalamic peptide that stimulates the secretion of corticotropin and β-endorphin. Science 1981, 213, 1394-1397.
4. Owens, M. J.; Nemeroff, C. B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 1991, 43, 425-474.
5. Uehara, A.; Sekiya, C.; Takasugi, Y.; Namiki, M.; Arimura, A. Anorexia induced by interleukin-1: Involvement of corticotropin-releasing factor. Am. J. Physiol. 1989, 257, R613-R617.
6. Strijbos, P. J.; Hardwick, A. J.; Relton, J. K.; Carey, F.; Rothwell, N. J. Inhibition of central action of cytokines on fever and thermogenesis by lipocortin-1 involves CRF. Am. J. Physiol. 1992, 263, E632-E636.
7. Rivier, C.; Vale, W. Influence of corticotropin-releasing factor on reproductive functions in the rat. Endocrinology 1984, 114, 914-928.
8. Vamvakopoulous, N. C.; Chrousus, G. P. Hormonal regulation of human corticotropin-releasing hormone gene expression: Implications for the stress response and immune/inflammatory reaction. Endocr. Rev. 1994, 15, 409-420.
9. Fisher, L. A.; Rivier, J.; Rivier, C.; Spiess, J.; Vale, W. W.; Brown, M. R. Corticotropin-releasing factor (CRF): Central effects on mean arterial pressure and heart rate. Endocrinology 1982, 110, 2222-2224.
10. Giguere, V.; Labrie, F.; Cote, J.; Coy, D. H.; Sueiras-Diaz, J.; Schally, A. V. Stimulation of cyclic AMP accumulation and corticotropin release by synthetic ovine corticotropin-releasing factor in rat anterior pituitary cells: site of glucocorticoid action. Proc. Natl. Acad. Sci. U.S.A. 1982, 79, 3467-3469.
11. Bilezikjian, L. M.; Vale, W. W. Glucocorticoids inhibit corticotropin-releasing factor-induced production of adenosine 3′,5′-monophosphate in cultured anterior pituitary cells. Endocrinology 1983, 113, 657-662.
12. Chang, C. P.; Pearse, R. V., II; O'Connel, S.; Rosenfeld, M. G. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 1993, 11, 1187-1195.
13. Chen, R.; Lewis, K. A.; Perrin, M. H.; Vale, W. W. Expression cloning of a human corticotropin-releasing factor receptor. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 8967-8971.
14. Perrin, M. H.; Donaldson, C. J.; Chen, R.; Lewis, K. A.; Vale, W. W. Cloning and functional expression of a rat brain corticotropin-releasing factor (CRF) receptor. Endocrinology 1993, 133, 3058-3061.
15. Vita, N.; Laurent, P.; Lefort, S.; Chalon, P.; Lelias, J.-M.; Kaghad, M.; Le Fur, G.; Caput, D.; Ferrara, P. Primary structure and functional expression of mouse pituitary and human brain corticotropin-releasing factor receptors. FEBS Lett. 1993, 335, 1-5.
16. Ross, P. C.; Kostas, Ch. M.; Ramabhadran, T. V. A variant of the human corticotropin-releasing factor (CRF) receptor: Cloning, expression and pharmacology. Biochem. Biophys. Res. Commun. 1994, 205, 1836-1842.
17. Lovenberg, T. W.; Liaw, Ch. W.; Grigoriadis, D. E.; Clevenger, W.; Chalmers, D. T.; DeSouza, E. B.; Oltersdorf, T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 836-840.
18. Kishimoto, T.; Pearse, R. V., II; Lin, Ch. R.; Rosenfeld, M. G. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 1108-1112.
19. Stenzel, P.; Kesterson, R.; Yeung, W.; Cone, R. D.; Rittenberg, M. B.; Stenzel-Poore, M. P. Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Mol. Endocrinol. 1995, 9, 637-645.
20. Xiong, Y.; Xie, L. Y.; Abou-Samra, A.-B. Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors: Decreased coupling efficiency of human type. Endocrinology 1995, 136, 1828-1834.
21. Hernandez, J.-F.; Kornreich, W.; Rivier, C.; Miranda, A.; Yamamoto, G.; Andrews, J.; Tache, Y.; Vale, W.; Rivier, J. Synthesis and relative potencies of new constrained CRF antagonists. J. Med. Chem. 1993, 36, 2860-2867.
22. Menzhagi, F.; Howard, R. L.; Heinrichs, St. C.; Vale, W.; Rivier, J.; Koob, G. F. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats. J. Pharmacol. Exp. Ther. 1994, 269, 564-572.
23. Rivier, J.; Rivier, C.; Galyean, R.; Miranda, A.; Miller, Ch.; Craig, A. G.; Yamamoto, G.; Brown, M.; Vale, W. Single point D-substituted corticotropin-releasing factor analogues: Effects on potency and physicochemical characteristics. J. Med. Chem. 1993, 36, 2851-2859.
24. Sawyer, T. K.; Staples, D. J.; Bannow, C. A.; Kinner, J. H.; Maggiora, L. L.; Evans, D.; Prairie, M.; Krueger, W.; Lahti, R. A. Design and structure/conformation-activity studies of a prototypic corticotropin-releasing factor (CRF) antagonist: Multiple alanine substitutions of CRF12-41. In Growth Factors, Peptides, and Receptors; Moody, T. W., Ed.; Plenum Press: New York, 1993; pp 21-28.
25. Pallai, P. V.; Mabilia, M.; Goodman, M.; Vale, W.; Rivier, J. Structural homology of corticotropin-releasing factor, sauvagine, and urotensin I: Circular dichroism and prediction studies. Proc. Natl. Acad. Sci. U.S.A. 1983, 80, 6770-6774.
26. Rivier, J.; Rivier, C.; Galyean, R.; Yamamoto, G.; Vale, W. Corticotropin-releasing factor: Characterization of new analogs. In Peptide Chemistry; Shiba, T., Sakakibara, S., Eds.; Protein Research Foundation: Osaka, Japan, 1988; pp 597-600.
27. Miranda, A.; Koerber, S. C.; Gulyas, J.; Lahrichi, S. L.; Craig, A. G.; Corrigan, A.; Hagler, A.; Rivier, C.; Vale, W.; Rivier, J. Conformationally restricted competitive antagonists of human/rat corticotropin-releasing Factor. J. Med. Chem. 1994, 37, 1450-1459.
28. Wei, E. T.; Thomas, H. A. Correlation of neuroendocrine and anti-edema activities of alanine corticotropin-releasing factor analogs. Eur. J. Pharmacol. 1994, 263, 319-321.
29. Roloff, B.; Beyermann, M.; Dathe, M.; Fabian, H.; Fechner, K.; Furkert, J.; Hagen, V.; Bienert, M. The effect of dibenzofuran substitutions in corticotropin-releasing factor. Lett. Pept. Sci. 1995, 2, 209-211.
30. Beck-Sickinger, A. G.; Wieland, H. A.; Wittneben, H.; Willim, K.; Rudolf, K.; Jung, G. Complete L-alanine scan of neuropeptide Y reveals ligands binding to Y1 and Y2 receptors with distinguished conformations. Eur. J. Biochem. 1994, 225, 947-958.
31. Wieczorek, Z.; Zimecki, M.; Pedyczak, A.; Lisowski, M.; Siemion, I. Z. Immunosuppressive activity of alanine analogs of cyclolinopeptide A. Arch. Immunol. Ther. Exp. 1993, 41, 291-296.
32. Stagsted, J.; Mapelli, C.; Meyers, C.; Matthews, B. W.; Anfinsen, C. B.; Goldstein, A.; Olsson, L. Amino acid residues essential for biological activity of a peptide derived from a major histocompatibility complex class I antigen. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 7686-7690.
33. Mimeault, M.; Quirion, R.; Dumont, Y.; St-Pierre, S.; Fournier, A. Structure-activity study of hCGRP8-37, a calcitonin gene-related peptide receptor antagonist. J. Med. Chem. 1992, 35, 2163-2168.
34. Kirby, D. A.; Boublik, J. H.; Rivier, J. E. Neuropeptide Y: Y1 and Y2 affinities of the complete series of analogs with single D-residue substitutions. J. Med. Chem. 1993, 36, 3802-3808.
35. He, Y. B.; Huang, Z.; Raynor, K.; Reisine, T.; Goodman, M. Synthesis and conformations of somatostatin-related cyclic hexapeptides incorporating specific alpha- and beta-methylated residues. J. Am. Chem. Soc. 1993, 115, 8066-8072.
36. Gulyas, J.; Rivier, C.; Perrin, M.; Koerber, S. C.; Sutton, S.; Corrigan, A.; Lahrichi, S. L.; Craig, A. G.; Vale, W.; Rivier, J. Potent structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 10575-10579.
37. 1H NMR and distance geometry with restrained molecular dynamics. Protein Eng. 1993, 6, 149-156.
38. Dathe, M.; Fabian, H.; Gast, K.; Zirwer, D.; Winter, R.; Beyermann, M.; Schümann, M.; Bienert, M. Conformational differences of ovine and human corticotropin-releasing hormone: A CD, IR, NMR and dynamic light scattering study. Int. J. Pept. Protein Res. 1996, 47, 383-393.
39. Krause, E.; Beyermann, M.; Dathe, M.; Rothemund, S.; Bienert, M. Location of an amphipathic α-helix in peptides using reversed-phase HPLC retention behavior of D-amino acid analogs. Anal. Chem. 1995, 34, 252-258.
40. Fairman, R.; Anthony-Cahill, S. J.; DeGrado, W. F. The helix-forming propensity of D-alanine in a right-handed α-helix. J. Am. Chem. Soc. 1992, 114, 5458-5459.
41. O'Neil, K. T.; DeGrado, W. F. A thermodynamic scale for the helix-forming tendencies of the commonly occurring amino acids. Science 1990, 250, 646-651.
42. Chakrabartty, A.; Kortemme, T.; Baldwin, R. L. Helix propensities of the amino acids measured in alanine-based peptides without helix-stabilizing side-chain interactions. Protein Sci. 1994, 3, 843-852.
43. Forood, B.; Feliciano, E. J.; Nambiar, K. P. Stabilization of α-helical structures in short peptides via end capping. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 838-842.
44. Strader, C. D.; Fong, T. M.; Graziano, M. P.; Tota, M. R. The family of G-protein-coupled receptors. FASEB J. 1995, 9, 745-754.
45. Hruby, V. J. Strategies in the development of peptide antagonists. In Progress in Brain Research; Joosse, J., Buijs, R. M., Tilders, F. J. H., Eds.; Elsevier Science Publishers B.V.: New York, 1992; Vol. 92, pp 215-224.
46. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
47. Denef, C.; Maertens, P.; Allaerts, W.; Mignon, A.; Robberecht, W.; Swennen, L.; Carmeliet, P. Cell-to-cell communication in peptide target cells of anterior pituitary. Methods Enzymol. 1989, 168, 47-71.